PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Wuzhi capsule (S. sphenanthera extract) attenuated liver steatosis and inflammation in a mouse model [PMID:30522014]
Oral anwulignan increased mesenteric blood microcirculatory flow velocity and reduced pathologic injury of the jejunum in rats [PMID:34131018]
Schisandrol B alleviated depression-like behavior in mice by regulating the brain-liver-gut axis [PMID:39809031]
Petroleum ether extracts and other fractions prevented hyperglycemia and insulin resistance in rat models [PMID:38718889, PMID:40471999]
Ethanolic extracts and specific 7,8-secolignans potently inhibited SARS-CoV-2 3CLpro and inflammation in vitro [PMID:39262656]
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 34559620 (2021) — Schisandra sphenanthera: A Comprehensive Review of its Botany, Phytochemistry, Pharmacology, and Clinical Applications. · The American journal of Chinese medicine
- 2.PMID: 18849034 (2009) — Analysis of Schisandra chinensis and Schisandra sphenanthera. · Journal of chromatography. A
- 3.PMID: 39809031 (2025) — Schisandrol B alleviates depression-like behavior in mice by regulating bile acid homeostasis in the brain-liver-gut axis via the pregnane X receptor. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 4.PMID: 34678416 (2022) — A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils. · Journal of ethnopharmacology
- 5.PMID: 29352909